Freeze-Dried plasma could offer new way to reverse blood thinners
NCT ID NCT04794348
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aimed to see if a freeze-dried plasma product (FDP) works as well as fresh frozen plasma (FFP) for reversing the blood-thinning effects of warfarin in healthy volunteers. Participants would have received both treatments in random order. However, the trial was withdrawn before any volunteers were enrolled, so no results are available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Freeze dried plasma (FDP) and fresh frozen plasma (FFP)
- What this could lead to
- If FDP works as well as FFP, it could provide a more convenient, shelf-stable option for reversing blood thinners in emergencies.
- What could go wrong
- The trial was withdrawn before any participants enrolled, so no data were collected. Even if tested, FDP may not work as well as FFP, and risks include allergic reactions or infection from plasma products.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTICOAGULANT REVERSAL are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hoxworth Blood Center
Cincinnati, Ohio, 45219, United States